1. Ahrnsbrak R, Bose J. Key Substance use and mental health indicators in the United States: results from the 2016 National Survey on Drug Use and Health. NSDUH Data Review 2017.
https://store.samhsa.gov/product/Key-Substance-Use-and-Mental-Health-Indicators-in-the-United-States-/SMA17-5044
. Accessed 18 Oct 2018.
2. Centers for Disease Control and Prevention. Opioid data analysis. 2018.
https://www.cdc.gov/drugoverdose/data/analysis.html
. Accessed 18 Oct 2018.
3. Budman SH, Grimes Serrano JM, Butler SF. Can abuse deterrent formulations make a difference? Expectation and speculation. Harm Reduct J. 2009;6:8.
4. Katz N, Dart RC, Bailey E, Trudeau J, Osgood E, Paillard F. Tampering with prescription opioids: nature and extent of the problem, health consequences, and solutions. Am J Drug Alcohol Abuse. 2011;37(4):205–17.
5. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Abuse-deterrent opioids: evaluation and labeling: guidance for industry; 2015.